A promising new medicine against heart disease fails unexpectedly

NPR | By Rob Stein

Published November 9, 2026 at 5:00 PM EST

Doctors expected an experimental drug that lowers a common risk factor for heart attacks would save patients' lives. The medicine made no difference.

Rob Stein

Rob Stein is a Correspondent and Senior Editor on NPR's Science Desk.

WEKU depends on support from those who view and listen to our content. There's no paywall here. Please support WEKU with your donation.

Contribute now

Related Content

Nvidia shares tumble as the company says it's investigating CEO Jensen Huang

John Ruwitch

Nvidia's share price falls after the company begins an investigation into CEO Jensen Huang's alleged relationship with a woman accused of being a Chinese spy.
Paraguay bank collapse hits millions

Catherine Osborn

A digital bank's collapse has plunged Paraguay into crisis — cutting millions off from their money and sending the president from office to detention in a matter of days.
Scientists think they've found ancient remnants of dinosaur blood

Nathan Rott

Scientists have studied plenty of dinosaur bones, eggs and footprints. Now, some think they've found their strongest evidence yet of dinosaur blood.
NPR News

Apocalyptic sci-fi novel 'The End of Everything' wins this year's Booker Prize

Andrew Limbong

M. John Harrison's slim novel is the first Booker Prize winner that's "emerged from the bona fide [sci-fi] world," according to the Booker Prize Foundation's chief executive.
A quest to make a young friend smile takes one man on a sweet international journey

Matt Ozug, Ashley Brown, Lauren Hodges

The fall 2026 Audio Flux storytelling competition features immersive short audio entries from around the world, including one about the search for an elusive box of cookies.